300 related articles for article (PubMed ID: 18397986)
1. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.
Maruyama T; Tanaka S; Shimada A; Funae O; Kasuga A; Kanatsuka A; Takei I; Yamada S; Harii N; Shimura H; Kobayashi T
J Clin Endocrinol Metab; 2008 Jun; 93(6):2115-21. PubMed ID: 18397986
[TBL] [Abstract][Full Text] [Related]
2. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
[TBL] [Abstract][Full Text] [Related]
3. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.
Kobayashi T; Maruyama T; Shimada A; Kasuga A; Kanatsuka A; Takei I; Tanaka S; Yokoyama J
Ann N Y Acad Sci; 2002 Apr; 958():117-30. PubMed ID: 12021091
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
[TBL] [Abstract][Full Text] [Related]
5. Exponential increase of glutamic acid decarboxylase (GAD) antibody titer after initiating and stopping insulin in a patient with slowly progressive type 1 diabetes.
Nishimura A; Nagasawa K; Okubo M; Kobayashi T; Mori Y
Endocr J; 2015; 62(12):1077-82. PubMed ID: 26440526
[TBL] [Abstract][Full Text] [Related]
6. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
[TBL] [Abstract][Full Text] [Related]
7. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report.
Maruyama T; Shimada A; Kanatsuka A; Kasuga A; Takei I; Yokoyama J; Kobayashi T
Ann N Y Acad Sci; 2003 Nov; 1005():362-9. PubMed ID: 14679093
[TBL] [Abstract][Full Text] [Related]
8. Interventions for latent autoimmune diabetes (LADA) in adults.
Brophy S; Davies H; Mannan S; Brunt H; Williams R
Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD006165. PubMed ID: 21901702
[TBL] [Abstract][Full Text] [Related]
9. Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).
Awata T; Shimada A; Maruyama T; Oikawa Y; Yasukawa N; Kurihara S; Miyashita Y; Hatano M; Ikegami Y; Matsuda M; Niwa M; Kazama Y; Tanaka S; Kobayashi T
Diabetes Ther; 2017 Oct; 8(5):1123-1134. PubMed ID: 28929327
[TBL] [Abstract][Full Text] [Related]
10. Interventions for latent autoimmune diabetes (LADA) in adults.
Brophy S; Brunt H; Davies H; Mannan S; Williams R
Cochrane Database Syst Rev; 2007 Jul; (3):CD006165. PubMed ID: 17636829
[TBL] [Abstract][Full Text] [Related]
11. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
[TBL] [Abstract][Full Text] [Related]
12. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
[TBL] [Abstract][Full Text] [Related]
13. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
[TBL] [Abstract][Full Text] [Related]
14. Slowly progressive type 1 diabetes treated with metformin for five years after onset.
Hirata T; Shimada A; Morimoto J; Maruyama T
Intern Med; 2013; 52(23):2635-7. PubMed ID: 24292754
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi T; Carlsson A; Li H; Isomaa B; Miettinen A; Nilsson A; Nissén M; Ehrnström BO; Forsén B; Snickars B; Lahti K; Forsblom C; Saloranta C; Taskinen MR; Groop LC
Diabetes; 1999 Jan; 48(1):150-7. PubMed ID: 9892237
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus.
Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P
Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
Roh MO; Jung CH; Kim BY; Mok JO; Kim CH
Acta Diabetol; 2013 Apr; 50(2):129-34. PubMed ID: 20953640
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM).
Tanaka S; Okubo M; Nagasawa K; Takizawa S; Ichijo M; Ichijo S; Kaneshige M; Aida K; Shimura H; Mori Y; Kobayashi T
Diabetol Int; 2016 Mar; 7(1):42-52. PubMed ID: 30603242
[TBL] [Abstract][Full Text] [Related]
19. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
